Our findings expand the genotypic spectrum of this condition and provide a molecular basis for further studies of the mechanisms underlying CASQ2‐associated CPVT in Chinese patients. The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.